For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Nelson Research & Development Company

Calculating rank

USPTO Granted Patents = 85

Forward Citations = 1,402

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Vithal J Rajadhyaksha (22 out of 31 patents)

Gevork Minaskanian (16 out of 41 patents)

Eric L Nelson (14 out of 29 patents)

4. James V Peck (14 out of 46 patents)

5. Alan S Horn (8 out of 14 patents)

6. Kjell Fuxe (6 out of 6 patents)

7. Richard B Stoughton (4 out of 4 patents)

8. Richard Allen Schroer (4 out of 4 patents)

9. Richard L Harris (4 out of 4 patents)

10. Kenneth E Eakins (4 out of 4 patents)

11. William O McClure (3 out of 3 patents)

12. Frank J Dea (3 out of 3 patents)

13. Georges D Cehovic (2 out of 2 patents)

14. Phillip J Brock (2 out of 2 patents)

15. Earl R Krueger (2 out of 2 patents)

Core Competencies:

Transdermal Delivery

Penetration Enhancers

Systemic Agents

Pharmaceutical Compositions

Dopamine Agonists

Microbicidal Solutions

Calcium Antagonists

1,4-Dihydropyridines

Ophthalmic Compositions

Topical Anti-Inflammatory

Plant Growth Regulators

Inhibition of Platelet Aggregation

85 patents: Sort by Forward Citations

1. 4954448 - Modulation of adenylate cyclase response (1990-09-04),

2. 4920101 - Compositions comprising 1-oxo- or thiohydrocarbyl substituted (1990-04-24),

3. 4917896 - Penetration enhancers for transdermal delivery of systemic agents (1990-04-17),

4. 4917688 - Bandage for transdermal delivery of systemically-active drug (1990-04-17),

5. 4912223 - 1,4-Dihydropyridines (1990-03-27),

6. 4908262 - Article with microbiocidal solution (1990-03-13),

7. 4902676 - Compositions comprising N,N-dialkylalkanamides (1990-02-20),

8. 4886783 - Penetration enhancers for transdermal delivery of systemic agents (1989-12-12),

9. 4886545 - Compositions comprising 1-substituted azacycloalkanes and their uses (1989-12-12),

10. 4885308 - Method and compositions for treatment of parkinsonism syndrome in mammals (1989-12-05),

11. 4882352 - Method for treating schizophrenia (1989-11-21),

12. 4880924 - Novel compounds and use thereof in selective cyclization process (1989-11-14),

13. 4879275 - Penetration enhancers for transdermal delivery of systemic agent (1989-11-07),

14. 4870173 - Lactam formation by a selective cyclization process (1989-09-26),

15. 4849436 - 1,4-dihydropyridines (1989-07-18),

Company Overview

Nelson Research & Development Company, based in Irvine, CA, specializes in innovative transdermal drug delivery systems. The company focuses on developing advanced pharmaceutical compositions that enhance the delivery of systemic agents through the skin. Key areas of research include penetration enhancers, dopamine agonists, and microbicidal solutions, as well as calcium antagonists and 1,4-dihydropyridines. Nelson Research is dedicated to improving therapeutic outcomes through its cutting-edge technology in the pharmaceutical field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

85 Patents

#43 in Irvine, CA

#1,015 in California

#4,380 in US

#8,970 in the World

Irvine, CA, United States of America

Nelson Research & Development Company

Forward Citations = 1,402

30 inventors:

Vithal J Rajadhyaksha (22 out of 31 patents)

Gevork Minaskanian (16 out of 41 patents)

Eric L Nelson (14 out of 29 patents)

4. James V Peck (14 out of 46 patents)

5. Alan S Horn (8 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nelson Research & Development Company. Retrieved from https://idiyas.com/company/nelson-research-and-development-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…